Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Prednisolone for Lumbar Facet Joint Syndrome
NCT05105256Completed
- Sponsor
- CHU de Reims
- Start
- Dec 2021
- Primary completion
- May 2024
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma in lumbar facet joint syndrome (LFS) (2 arms), sponsored by CHU de Reims. Primary endpoint: 50% improvement in numerical pain scale at 6 months. Started Dec 2021; status: completed.
02
Drugs
platelet-rich plasma
03
Conditions
lumbar facet joint syndrome (LFS)
Beyond the preview
Go deeper on NCT05105256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05105256.